Altamirano De La Cruz Azalea Guadalupe, Santoyo Reza César Alberto, Lugo Rincón-Gallardo Francisco Javier, Ramírez Saavedra Abraham, Diaz Mendoza Karen Alejandra
Internal Medicine, Mexican Social Security Institute (IMSS) General Zone Hospital No. 8, Ensenada, MEX.
Internal Medicine, Mexican Social Security Institute (IMSS) General Zone Hospital No. 57, Cuautitlán Izcalli, MEX.
Cureus. 2025 Jul 19;17(7):e88333. doi: 10.7759/cureus.88333. eCollection 2025 Jul.
Amelanotic melanoma represents an uncommon and aggressive variant of cutaneous melanoma. The characteristic absence of pigmentation poses significant diagnostic challenges, frequently leading to delayed clinical recognition and unfavorable prognosis compared to conventional pigmented melanomas. We report a 57-year-old Caucasian male patient with a medical history of amelanotic melanoma of the right foot surgically treated in 2010. The patient subsequently lost medical follow-up and presented 13 years later with nonspecific left upper quadrant abdominal pain. Comprehensive evaluation revealed extensive metastatic disease involving multiple organ systems. Chest computed tomography demonstrated bilateral pulmonary nodules with characteristic "cannonball" morphology, while brain magnetic resonance imaging revealed multiple intraparenchymal lesions with surrounding vasogenic edema. Physical examination disclosed multiple erythematous cutaneous nodules on the thorax and extremities, bilateral lymphadenopathy, and hepatosplenomegaly. Dermoscopic examination of cutaneous lesions revealed pathognomonic "milky-red areas" and polymorphous atypical vascular patterns, including irregular linear, dotted, and corkscrew vessels. Histopathological analysis of a cervical lymph node biopsy confirmed metastatic epithelioid amelanotic melanoma, with immunohistochemistry demonstrating positive staining for S100, Melan-A, and CDX10, while cytokeratin AE1/AE3 was negative. This case exemplifies the unpredictable biology of amelanotic melanoma, an uncommon and aggressive variant of cutaneous melanoma. Underscoring the critical importance of lifelong dermatological surveillance, advanced imaging techniques, and dermoscopic evaluation in managing this aggressive malignancy. Contemporary immunotherapy and targeted therapies offer significant therapeutic advances for patients with advanced metastatic disease, emphasizing the need for multidisciplinary management and sustained clinical vigilance in optimizing patient outcomes.
无色素性黑色素瘤是皮肤黑色素瘤中一种罕见且侵袭性强的亚型。其特征性的色素缺失带来了重大的诊断挑战,与传统色素性黑色素瘤相比,常常导致临床识别延迟和预后不良。我们报告一例57岁的白种男性患者,其有右脚无色素性黑色素瘤病史,于2010年接受了手术治疗。该患者随后失去了医学随访,13年后因左上腹非特异性腹痛就诊。全面评估显示广泛的转移性疾病累及多个器官系统。胸部计算机断层扫描显示双侧肺结节,具有特征性的“炮弹”形态,而脑部磁共振成像显示多个脑实质内病变,周围有血管源性水肿。体格检查发现胸部和四肢有多个红斑性皮肤结节、双侧淋巴结肿大以及肝脾肿大。对皮肤病变进行皮肤镜检查发现了具有诊断意义的“乳红色区域”和多形性非典型血管形态,包括不规则线性、点状和螺旋状血管。颈部淋巴结活检的组织病理学分析证实为转移性上皮样无色素性黑色素瘤,免疫组织化学显示S100、Melan - A和CDX10呈阳性染色,而细胞角蛋白AE1/AE3呈阴性。该病例例证了无色素性黑色素瘤不可预测的生物学特性,它是皮肤黑色素瘤中一种罕见且侵袭性强的亚型。强调了终身皮肤监测、先进成像技术和皮肤镜评估在管理这种侵袭性恶性肿瘤中的至关重要性。当代免疫疗法和靶向疗法为晚期转移性疾病患者带来了显著的治疗进展,强调了在优化患者预后方面多学科管理和持续临床警惕的必要性。